Release: Vascular Therapies Appoints John McDermott as Chief Executive Officer

Release: Vascular Therapies Appoints John McDermott as Chief Executive Officer

Source: 
CP Wire
snippet: 

Cresskill, NJ.  Vascular Therapies, a biotechnology company focused on improving outcomes for patients with advanced kidney disease today announced the appointment of John McDermott as the Company’s Chief Executive Officer.